IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D.
IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

IPTLD® a Registered Trademark by Donato Perez Garcia,MD
Copyright ©1930-2017 Donato Perez Garcia.



Tuesday, August 4, 2015

INTERESTING HISTORICAL FACTS ABOUT THE CREATOR OF IPT®

Did you know ...?
* The inventor of IPT® was a skillful surgeon in Obstetrics gynecology and urology.
* He first injected himself with insulin in 1930, as an experiment to cure him from a lifelong gastrointestinal illness that almost killed him.
* In 1930, he cured his first patient from syphilis using IPT®.
* His work at the San Diego Naval Hospital earned him an article on the April 10th 1944 edition of TIME Magazine.
* In 1946 he successfully treated, for the very first time, a cancer patient, achieving full remission.

HISTORICAL NOTE: Back in those days, oncology was an inexistent specialty in medicine. The first research done on nitrogen mustard for the treatment of leukemia was done in the USA by the year 1946.
Dr. Sidney Farber, from the School of Medicine in Harvard applied methotrexate and folic acid on a patient with Leukemia and achieved his remission.

At that time, Dr. Farber was criticized and ridiculed for this attempt. Years after, he was given credit for being the creator of chemotherapy.

* During Dr. Donato’s medical trajectory with IPT®, he too was criticized and ridiculed for his idea. Even his two descendants, Dr.Donato Jr. and Son, where subject to that rejection, for bringing forth a treatment that was unheard of but proved to have good medical response.

* Back in those days, curing gastric ulcers with something other than surgery was seen as “quackery”, Donato cured this condition using IPT®, bismuth and sulfa salts. He was criticized by the medical society, stating that no such thing could be cured just using a syringe. By 1991 the bacteria H.Pylori was then discovered to be the cause of most of the gastric ulcers.

* Donato used insulin before lunch every day, for the rest of his life, and enjoyed good health. He was a non-diabetic.

CONCLUSION: Every distinguished inventor who brought new ideas and methods to those commonly known, has been rejected and criticized by colleagues and public at that time. Only continuous proof of efficiency and MUCH MUCH TIME, will come to prove his success and acceptance. Just because it is unheard of, doesn’t mean it’s untrue or inefficient. IPT® has also suffered this kind of rejection, till this very day. Yet for over 80 years of existence, anecdotal testimonies show that it has persistently proven to cure many illnesses and medical conditions, in a non-traditional way.

Monday, August 3, 2015

Cellular “Hack” with IPTLD


Cancer is the apparition of one o more abnormal cells in a healthy tissue, that will begin to grow until forming a mass called tumor.

This cancer cell apparition in a healthy tissue causes the release of chemical substances that the body will interpret as “damage”. This chemical information prepares the defense mechanism to send help; releasing immune cells, forming new blood vessels to help with repair, starting a protective process for the infiltrated tissue caused by cancer cells.

Many cancer drugs used to treat this anomaly are mostly tested in a lab, on animals or patients with a highly developed cancer, that may not always be the case of the patient that’s being treated. This can ultimately weaken the immune system and the dosages used are too elevated. Administering this medication is no guarantee that it will penetrate into the malignant cells, it may also affect healthy cells and the process can be prolonged, with very aggressive side effects for most patients.


There is a better way of administering this  anti cancer medication, it is possible to “hack” the cancer cell’s membrane, opening a door into the damaged cell and administrating less dosage of the drug. The “hacking” method is called Insulin Potentiation Therapy Low Dose or IPTLD. It’s done in a natural way using insulin properties that, when knowing how to manipulate, may target only cancer cells, opening their membrane and in just the right moment, releasing the medication that will eventually eliminate them, and with that, the malignant tumor.

Cell membrane “hack” is possible, it’s called Insulin Potentiation Therapy.
To read more, visit: www.iptldmd.com